Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
American Journal of Obstetrics and Gynecology
|
September 15, 1970
Abortifacient and teratogenic effects of triacetyl-6-azauridine in the monkey
G van Wagenen, R C DeConti, R E Handschumacher, et al.
Cancer Research
|
June 1, 1970
Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue"
R L Capizzi, R C DeConti, J C Marsh, et al.
Cancer Chemotherapy Reports
|
December 1, 1971
Short-term sequential therapy with vinblastine (NSC-49842) and cyclophosphamide (NSC-26271) in Hodgkin's disease
R C DeConti, M S Mitchell, J C Marsh, et al.
Cancer
|
December 15, 1982
A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma
D A Schoenfeld, C Rosenbaum, J Horton, et al.
Connecticut Medicine
|
July 1, 1972
Comprehensive care of adult acute leukemia
R T Skeel, R C DeConti, J C Marsh, et al.
Cancer
|
June 4, 1998
Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390)
A A Forastiere, D Shank, D Neuberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 22, 2010
Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanoma
A Y Bedikian, R C DeConti, R Conry, et al.
Cancer
|
July 1, 1973
Development of a combination chemotherapy program for adult acute leukemia: CAM and CAM-L
R T Skeel, J C Marsh, R C DeConti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2001
Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393
A A Forastiere, T Leong, E Rowinsky, et al.
Cancer
|
March 1, 1985
Survival following moderate-dose preoperative radiation therapy for carcinoma of the rectum
P Friedmann, J L Garb, W C Park, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
American Journal of Obstetrics and Gynecology
|
September 15, 1970
Abortifacient and teratogenic effects of triacetyl-6-azauridine in the monkey
G van Wagenen, R C DeConti, R E Handschumacher, et al.
Cancer Research
|
June 1, 1970
Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue"
R L Capizzi, R C DeConti, J C Marsh, et al.
Cancer Chemotherapy Reports
|
December 1, 1971
Short-term sequential therapy with vinblastine (NSC-49842) and cyclophosphamide (NSC-26271) in Hodgkin's disease
R C DeConti, M S Mitchell, J C Marsh, et al.
Cancer
|
December 15, 1982
A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma
D A Schoenfeld, C Rosenbaum, J Horton, et al.
Connecticut Medicine
|
July 1, 1972
Comprehensive care of adult acute leukemia
R T Skeel, R C DeConti, J C Marsh, et al.
Cancer
|
June 4, 1998
Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390)
A A Forastiere, D Shank, D Neuberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 22, 2010
Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanoma
A Y Bedikian, R C DeConti, R Conry, et al.
Cancer
|
July 1, 1973
Development of a combination chemotherapy program for adult acute leukemia: CAM and CAM-L
R T Skeel, J C Marsh, R C DeConti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2001
Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393
A A Forastiere, T Leong, E Rowinsky, et al.
Cancer
|
March 1, 1985
Survival following moderate-dose preoperative radiation therapy for carcinoma of the rectum
P Friedmann, J L Garb, W C Park, et al.
Page
of 5